Abstract
Glucose and oxygen metabolism are tightly coupled in the human brain, with the preponderance of the brain’s glucose supply used to generate ATP via oxidative phosphorylation. A fraction of glucose is consumed outside of oxidative phosphorylation despite the presence of sufficient oxygen to do so. We refer to this process as aerobic glycolysis. A recent positron emission tomography study reported that aerobic glycolysis is uniform within gray matter. Here, we analyze the same data and demonstrate robust regional differences in aerobic glycolysis within gray matter, a finding consistent with previously published data.
Keywords: Brain imaging, energy metabolism, glucose, metabolism, positron emission tomography
Introduction
The energetic needs of the healthy human brain are almost entirely met by oxidative consumption of blood-borne glucose.1,2 However, a fraction of the brain's glucose uptake does not undergo oxidative phosphorylation. This effect conventionally is quantitated using the oxygen-glucose index (OGI), which is the molar ratio of oxygen to glucose consumption. If no alternative fuels are used and all glucose undergoes complete oxidative phosphorylation, the OGI is exactly 6. However, multiple studies have shown that the OGI of the young adult human brain is less than 6, typically on the order of 5.5.3–7 Thus, around 10% of the whole brain’s glucose consumption is metabolized through non-oxidative pathways. We define aerobic glycolysis (AG) as the fraction of glucose metabolized outside of oxidative phosphorylation. AG is defined inversely proportional to OGI; thus, areas of the brain that have high AG have low OGI ratios and vice versa.
Prior work from our laboratory has shown that, in resting, healthy young adults, AG is regionally greater in prefrontal cortex, lateral parietal lobe, and the precuneus/posterior cingulate cortex, relative to the rest of the brain.8 These regions correspond to the default mode and fronto-parietal control (FPC) networks, which are areas of the cerebral cortex associated with higher-order cognition.9 Conversely, AG in the cerebellum has been shown by us,8 and others,10 to be lower than in the rest of the brain. Hyder et al.7 recently published a study disputing the existence of regional variability in AG. Using quantitative positron emission tomography (PET) techniques, Hyder et al. measured OGI in 13 normal volunteers and reported that OGI is uniform within gray matter, which implies that AG is uniform as well. In the following, we refer to this study as “Hyder et al.” To resolve the discrepancy between Hyder et al. and our previous findings, we reanalyzed the PET data from Hyder et al., which was generously shared with us by the original authors.
Methods
Dataset
We obtained processed, quantitative PET images of cerebral blood flow (CBF), oxygen utilization (CMRO2), and glucose consumption (CMRGlc) for 13 normal adult males from Hyder et al.7 CBF and CMRO2 were measured using [15O]H2O and [15O]O2, respectively. A two-compartment (tissue and vascular distribution) kinetic model was used for both tracers.11,12 No correction for recirculating [15O]H2O was performed during [15O]O2 modeling. CMRGlc was obtained by fitting an irreversible two-compartment (free [18F]FDG and trapped [18F]FDG-6-phosophate) model to the [18F]FDG data.13 No correction for vascular radioactivity was performed, and a lumped constant of 0.8 was used. All PET imaging data were acquired with arterial sampling, allowing for absolute quantitation of all metabolic parameters. For further methodological details, please see the original publication.7 As stated in the original report by Hyder et al.,7 all subjects gave written informed consent in accordance with the Helsinki Protocol and all experimental procedures were approved by the ethical review committees of the Central Denmark Region and the Aarhus University Hospital, Aarhus Denmark.
OGI regional computations
To assess regional differences in AG, we first calculated voxelwise OGI (CMRO2/CMRGlc) in each subject. We then computed regional average OGI values in several regions of interest (ROI). Prior to computing regional means, we excluded voxels that were outside five median absolute deviations (1.11) from the gray matter median (4.83).14 Excluded voxels were predominantly in areas of vascular artifact or on the edges of the PET images (4.09% of all voxels were excluded). We also excluded any voxels that were not classified as gray matter in the atlas used by Hyder et al.7
Our primary ROI set comprised seven resting state networks (Figure 1(a)), defined in a previous resting-state functional magnetic resonance imaging study.15 Each ROI included only voxels in which the likelihood of network identity exceeded 90%. Resting state ROIs were transformed, using FSL,16,17 into the atlas space used by Hyder et al. without alterations of the metabolic imaging data. We also created an ROI of the cerebellar gray matter within the atlas used by Hyder et al.7 To accommodate incomplete cerebellar coverage of the PET data, the present results are limited to portions of the cerebellum in which the OGI was measured in every subject (Supplementary Figure 1).
Statistical methods
All statistical analyses were conducted in R.18 A one-way ANOVA with region as a factor and subject as a repeated measure was used to determine if brain region explained any variance in OGI. Statistical significance was determined using an F-test on the region factor. One sample t-tests were used to determine if regional OGI values were different from 6. An OGI significantly (p < 0.05, two-tailed) less than 6 means that the probability of finding such, or more extreme, data by chance is below 5%. We took this as indication that a portion of the glucose consumption in a given region undergoes only AG. In the same sense, paired t-tests were used to assess differences in OGI between regions. We used a significant difference (p < 0.05, two-tailed) as indication that AG is different between two regions. Correction for the 21 pairwise comparisons between networks was performed using false discovery rate (FDR) theory.19 Reported values are means and 95% confidence intervals unless otherwise stated.
The statistical thresholds that we defined above are dependent on the power of the Hyder et al. dataset. To determine the power of the Hyder et al. data, we performed a power analysis using two previously published PET datasets. All power calculations were performed using the R package pwr.20 Sasaki et al. reported the mean difference between the cortical and cerebellar gray matter OGI to be −1.48 (SD = 0.42; n = 7).10 The 13 subjects in the Hyder et al. dataset give us 100% power to detect an effect of this magnitude. The mean OGI difference between the cortical gray matter and the basal ganglia was found by Hatazwa et al. to be 0.38 (SD = 0.93; n = 7).21 The Hyder et al. dataset would provide only 17.2% power to detect this effect. Taken together, these analyses reveal that we are more than sufficiently powered to detect large regional differences, but are unlikely to capture smaller effects.
Results
AG varies by resting state network
To assess regional differences in AG, we computed OGI in seven resting state network (Figure 1(a)). The means for other metabolic parameters (e.g. CBF) are reported in Supplemental Table 1. With the exception of the visual network (VIS), all resting state networks had an OGI significantly less than 6 (p < 0.05), indicating the presence of AG. A repeated measures, one-way ANOVA revealed a highly significant difference in OGI across the brain (F6,72 = 74.16, p < 0.001). Differences in OGI between specific network pairs are shown in Figure 1(b); the RSNs are ordered by OGI and significant differences (p < 0.05, corrected) are highlighted by color. In agreement with previous work,8 the OGI was low in default mode network (DMN) and high in the visual network (VIS). Unexpectedly, the ventral attention (VAN) network had the lowest OGI. We note that these regional differences were highly consistent. For example, OGI in the DMN was less than OGI in the visual network (VIS) in every subject (Figure 1(c)).
AG in the cerebellum
Previous studies have shown that AG in the cerebellum is lower than that in the rest of the brain.8,10 In the Hyder et al. data, the OGI in the superior cerebellum (see Methods) was 6.50 (±0.67), which was not significantly different from 6.0 (t = 1.63, p = 0.13). The difference between the cerebellum and the rest of gray matter (5.18 ± 0.51) was significant (t = −8.70, p < 0.001). As the lumped constant in the cerebellum has been reported to be approximately 1.14 times greater than in the whole brain,22 we repeated our analysis after adjusting the cerebellum OGI for this difference. After the adjustment, the cerebellar OGI was 5.70 (±0.58), again not significantly different from 6.0 (t = −1.12, p = 0.28), but still significantly different from the rest of gray matter (t = −4.00, p = 0.0018). Thus, the cerebellum is characterized by a distinct lack of AG.
Topography of OGI
The present results indicate that regional differences in AG exist between resting state networks as well as between the cerebellar and non-cerebellar gray matter. Figure 2(a) shows group averaged OGI (image obtained from the original authors) at a finer spatial scale. This figure is essentially identical to Figure 3(a) in Hyder et al. (reproduced here as Figure 2(b)) except for choice of color scale. Thus, presenting the identical results using a more physiologically meaningful scale (4–7 in Figure 2(a) as opposed to 1–10 in Figure 2(b)) demonstrates regional differences in OGI on inspection.
Discussion
Our reexamination of the data from Hyder et al. reveals two primary findings. First, many regions of the brain exhibit AG at rest. This result is consistent with both the regional PET literature10,21 as well as with whole-brain measurements of OGI.3–6 Second, we observed significant regional differences in AG between gray matter regions that were highly preserved across subjects (Figure 1(c)).
These findings are consistent with Vaishnavi et al.,8 a previous study from our group that employed regional standardized uptake ratios. The principal result of that study was that AG is significantly non-uniform across the brain. In particular, regions constituting the default mode network (DMN) had higher AG than other parts of the brain. In contrast, the cerebellum had lower AG. These findings are replicated here using the Hyder et al. dataset. There are, however, a few differences between the two datasets. The FPC network had higher AG in the Vaishnavi et al. study compared to Hyder et al., and the AG in the ventral attention network (VAN) was much higher in the Hyder et al. data compared to Vaishnavi et al. (Figure 1(b) and (c)). It is not clear whether these differences are attributable to analytical approach (relative vs. quantitative PET), study population (the Hyder et al. study contained only male subjects), or other unknown factors. Therefore, although both datasets clearly support regional differences, more work is needed to resolve the discrepancies between the two studies.
On the basis of the same dataset, Hyder et al. argued that no regional differences in AG exist, and that findings reported by Vaishnavi et al. are artifacts attributable to the use of relative metabolic measures. The present results, obtained using the quantitative data identical to that from the Hyder et al. study, do not support this perspective. It follows that the discrepant perspectives are attributable to difference in analysis methodology. Specifically, Hyder et al. did not account for subject level variability common to all regions (e.g. use of ANOVA without a repeated measures factor). Figure 1(c) illustrates how OGI measures in two regions would appear to be not significantly different if variability attributable to subject is not taken into account.
Could observed regional difference arise from non-biological artifact? PET involves many technical decisions including choosing a kinetic model, accounting for vascular radioactivity, adjusting for recirculating metabolites, and correcting for the delay and dispersion of the arterial input function. Any of these factors could, in theory, produce an artefactual regional difference in AG. However, we think this unlikely for several reasons. First, despite the fact that there are regional differences in cerebral blood volume23 and arterial delay,24 there is no direct evidence that any of these technical factors produce a spatial artifact that induces regional differences in OGI. Second, using different procedures to analyze PET data, we8 and others10 have found regional differences in OGI similar to the present findings. Finally, additional evidence from different techniques suggests that AG varies throughout the brain. Using microdialysis in a transgenic mouse model of Alzheimer’s disease (AD), Bero et al.25 reported regional differences in lactate levels in interstitial fluid, a result consistent with regional differences in AG. Taken together, the available evidence supports the conclusion that regional differences in OGI are of biological origin.
In the Hyder et al. dataset, AG accounts for 5.57 (±2.65) µMol/hg/min, or approximately 19%, of the glucose consumption in the DMN. From an energetic perspective, it may be surprising that AG accounts for so much glucose consumption in any part of the brain, as the quantity of ATP generated by AG is quite small compared to that generated by oxidative phosphorylation.7 Therefore, a number of alternative explanations have been proposed, including rapid synthesis of ATP for the Na+/K+-ATPase,26 generation of biosynthetic intermediates necessary for myelination as well as synaptic and neuritic formation and turnover,8 alteration of cellular redox potentials,27 regulation of glycogen levels through a hypothesized glycogen shunt,28 and the uptake and recycling of glutamate by astrocytes.29,30 The exact apportionment of AG among these alternatives remains uncertain.
One way to elucidate the role of AG in the brain is through spatial topography. Past work in our laboratory has shown that the spatial distribution of AG correlates with the expression of genes related to synaptic development and growth.31 The relationship between AG and synaptic plasticity is particularly intriguing given previous findings relating AG to task performance. Madsen et al.32 found that whole brain AG was elevated both during and after performance of the Wisconsin Card Sorting Test. Our group recently expanded on this finding. We measured regional OGI in subjects before and after the performance of a covert motor learning task.33 We found that hours after the performance of the learning task, subjects had elevated AG in the left Brodmann area 44, an area recruited by task performance. Furthermore, we observed a correlation between task performance and subsequent increases in AG. These results link focal changes in AG to learning and suggest that regional differences in AG might reflect regional differences in synaptic plasticity.
Other experiments have focused on the role of AG in aging and AD. For example, it has been shown that higher levels of neural activity lead to increased amyloid-beta production in a mouse model of AD.25 Moreover, this effect is associated with increased lactate levels in the interstitial fluid.25 Cross-sectional studies in humans have found that brain AG decreases in AD34,35 as well as in normal aging36 (two smaller aging studies have reported non-significant trends37,38). One interpretation of these findings is that the same processes that lead to high AG and synaptic plasticity in early life may ultimately lead to disease later in life.39,40
Synaptic plasticity is but one of several, non-exclusive explanations for the brain’s use of AG. Much more work is needed before AG in the brain is fully understood.43 Any explanation of AG will need to consider regional differences, which have now been reproduced in an independent dataset. It is our hope that this report will serve as an impetus for new research that will further elucidate the role AG in the brain.
Supplemental Material
Supplemental material for Quantitative positron emission tomography reveals regional differences in aerobic glycolysis within the human brain by Tyler Blazey, Abraham Z Snyder, Yi Su, Manu S Goyal, John J Lee, Andrei G Vlassenko, Ana Maria Arbeláez and Marcus E Raichle in Journal of Cerebral Blood Flow & Metabolism
Acknowledgements
We thank Fahmeed Hyder and his colleagues for generously sharing their data with us.
Funding
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by National Institutes of Health grants P01NS080675 (to MER), R21EB024366 (to YS) and 1P30NS098577, as well as funding from the McDonnell Center for Systems Neuroscience at Washington University.
Declaration of conflicting interests
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Authors’ contributions
TB analyzed data. TB and AZS drafted the manuscript. TMB, AZS, JJL, YS, AMA, AGV, MSG, and MER assisted in revising the manuscript and approved the final version.
Supplementary material
Supplementary material for this paper can be found at the journal website: http://journals.sagepub.com/home/jcb.
References
- 1.Gibbs EL, Lennox WG, Nims LF, et al. Arterial and cerebral venous blood arterial-venous differences in man. J Biol Chem 1942; 144: 325–332. [Google Scholar]
- 2.Siesjö BK. Brain energy metabolism, New York, NY: John Wiley & Sons, 1978. [Google Scholar]
- 3.Cohen PJ, Alexander SC, Smith TC, et al. Effects of hypoxia and normocarbia on cerebral blood flow and metabolism in conscious man. J Appl Physiol 1967; 23: 183–189. [DOI] [PubMed] [Google Scholar]
- 4.Raichle ME, Posner JB, Plum F. Cerebral blood flow during and after hyperventilation. Arch Neurol 1970; 23: 394–403. [DOI] [PubMed] [Google Scholar]
- 5.Boyle PJ, Scott JC, Krentz AJ, et al. Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans. J Clin Invest 1994; 93: 529–535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Rasmussen P, Wyss MT, Lundby C. Cerebral glucose and lactate consumption during cerebral activation by physical activity in humans. FASEB J 2011; 25: 2865–2873. [DOI] [PubMed] [Google Scholar]
- 7.Hyder F, Herman P, Bailey CJ, et al. Uniform distributions of glucose oxidation and oxygen extraction in gray matter of normal human brain: no evidence of regional differences of aerobic glycolysis. J Cereb Blood Flow Metab 2016; 36: 903–916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Vaishnavi SN, Vlassenko AG, Rundle MM, et al. Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci U S A 2010; 107: 17757–17762. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Zhang D, Raichle ME. Disease and the brain's dark energy. Nat Rev Neurol 2010; 6: 15–28. [DOI] [PubMed] [Google Scholar]
- 10.Sasaki H, Kanno I, Murakami M, et al. Tomographic mapping of kinetic rate constants in the fluorodeoxyglucose model using dynamic positron emission tomography. J Cereb Blood Flow Metab 1986; 6: 447–454. [DOI] [PubMed] [Google Scholar]
- 11.Ohta S, Meyer E, Thompson CJ, et al. Oxygen consumption of the living human brain measured after a single inhalation of positron emitting oxygen. J Cereb Blood Flow Metab 1992; 12: 179–192. [DOI] [PubMed] [Google Scholar]
- 12.Ohta S, Meyer E, Fujita H, et al. Cerebral [15O]water clearance in humans determined by PET: I. Theory and normal values. J Cereb Blood Flow Metab 1996; 16: 765–780. [DOI] [PubMed] [Google Scholar]
- 13.Kuwabara H, Gjedde A. Measurements of glucose phosphorylation with FDG and PET are not reduced by dephosphorylation of FDG-6-phosphate. J Nucl Med 1991; 32: 692–698. [PubMed] [Google Scholar]
- 14.Leys C, Ley C, Klein O, et al. Detecting outliers: do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol 2013; 49: 764–766. [Google Scholar]
- 15.Hacker CD, Laumann TO, Szrama NP, et al. Resting state network estimation in individual subjects. Neuroimage 2013; 82: 616–633. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jenkinson M, Smith S. A global optimisation method for robust affine registration of brain images. Med Image Anal 2001; 5: 143–156. [DOI] [PubMed] [Google Scholar]
- 17.Jenkinson M, Beckmann CF, Behrens TEJ, et al. FSL. Neuroimage 2012; 62: 782–790. [DOI] [PubMed] [Google Scholar]
- 18.R Core Team. R: a language and environment for statistical computing. Vienna, Austria, 2017.
- 19.Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995; 57: 289–300. [Google Scholar]
- 20.Champely S. pwr, https://CRAN.R-project.org/package=pwr (accessed 11 March 2018).
- 21.Hatazawa J, Ito M, Matsuzawa T, et al. Measurement of the ratio of cerebral oxygen consumption to glucose utilization by positron emission tomography: its consistency with the values determined by the Kety-Schmidt method in normal volunteers. J Cereb Blood Flow Metab 1988; 8: 426–432. [DOI] [PubMed] [Google Scholar]
- 22.Graham MM, Muzi M, Spence AM, et al. The FDG lumped constant in normal human brain. J Nucl Med 2002; 43: 1157–1166. [PubMed] [Google Scholar]
- 23.Grubb RL, Raichle ME, Higgins CS, et al. Measurement of regional cerebral blood volume by emission tomography. Ann Neurol 1978; 4: 322–328. [DOI] [PubMed] [Google Scholar]
- 24.Iida H, Higano S, Tomura N, et al. Evaluation of regional differences of tracer appearance time in cerebral tissues using [15O] water and dynamic positron emission tomography. J Cereb Blood Flow Metab 1988; 8: 285–288. [DOI] [PubMed] [Google Scholar]
- 25.Bero AW, Yan P, Roh JH, et al. Neuronal activity regulates the regional vulnerability to amyloid-β deposition. Nat Neurosci 2011; 14: 750–756. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Pellerin L, Magistretti PJ. Excitatory amino acids stimulate aerobic glycolysis in astrocytes via an activation of the Na+/K+ ATPase. Dev Neurosci 1996; 18: 336–342. [DOI] [PubMed] [Google Scholar]
- 27.Cerdán S, Rodrigues TB, Sierra A, et al. The redox switch/redox coupling hypothesis. Neurochem Int 2006; 48: 523–530. [DOI] [PubMed] [Google Scholar]
- 28.Shulman RG, Hyder F, Rothman DL. Cerebral energetics and the glycogen shunt: neurochemical basis of functional imaging. Proc Natl Acad Sci U S A 2001; 98: 6417–6422. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Sonnewald U. Glutamate synthesis has to be matched by its degradation - where do all the carbons go? J Neurochem 2014; 131: 399–406. [DOI] [PubMed] [Google Scholar]
- 30.Dienel GA, McKenna MC. A dogma-breaking concept: glutamate oxidation in astrocytes is the source of lactate during aerobic glycolysis in resting subjects. J Neurochem 2014; 131: 395–398. [DOI] [PubMed] [Google Scholar]
- 31.Goyal MS, Hawrylycz M, Miller JA, et al. Aerobic glycolysis in the human brain is associated with development and neotenous gene expression. Cell Metab 2014; 19: 49–57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Madsen PL, Hasselbalch SG, Hagemann LP, et al. Persistent resetting of the cerebral oxygen/glucose uptake ratio by brain activation: evidence obtained with the Kety-Schmidt technique. J Cereb Blood Flow Metab 1995; 15: 485–491. [DOI] [PubMed] [Google Scholar]
- 33.Shannon BJ, Vaishnavi SN, Vlassenko AG, et al. Brain aerobic glycolysis and motor adaptation learning. Proc Natl Acad Sci USA 2016; 113: E3782–E3791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Fukuyama H, Ogawa M, Yamauchi H, et al. Altered cerebral energy metabolism in Alzheimer's disease: a PET study. J Nucl Med 1994; 35: 1–6. [PubMed] [Google Scholar]
- 35.Ogawa M, Fukuyama H, Ouchi Y, et al. Altered energy metabolism in Alzheimer's disease. J. Neurol Sci 1996; 139: 78–82. [PubMed] [Google Scholar]
- 36.Goyal MS, Vlassenko AG, Blazey TM, et al. Loss of brain aerobic glycolysis in normal human aging. Cell Metab 2017; 26: 353–360.e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Dastur DK. Cerebral blood flow and metabolism in normal human aging, pathological aging, and senile dementia. J Cereb Blood Flow Metab 1985; 5: 1–9. [DOI] [PubMed] [Google Scholar]
- 38.Fisher JP, Hartwich D, Seifert T, et al. Cerebral perfusion, oxygenation and metabolism during exercise in young and elderly individuals. J Physiol 2013; 591: 1859–1870. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005; 25: 7709–7717. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Bufill E, Agustí J, Blesa R. Human neoteny revisited: the case of synaptic plasticity. Am J Hum Biol 2011; 23: 729–739. [DOI] [PubMed] [Google Scholar]
- 41.Van Essen DC, Glasser MF, Dierker DL, et al. Parcellations and hemispheric asymmetries of human cerebral cortex analyzed on surface-based atlases. Cereb Cortex 2012; 22: 2241–2262. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Marcus DS, Harms MP, Snyder AZ, et al. Human Connectome Project informatics: quality control, database services, and data visualization. Neuroimage 2013; 80: 202–219. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. doi: 10.1371/journal.pone.0204242. Blazey T, Snyder AZ, Goyal MS, et al. A systematic meta-analysis of oxygen-to glucose and oxygen-to carbohydrate ratios in the resting human brain. PLoS ONE 2018; 13: e0204242. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Supplemental material for Quantitative positron emission tomography reveals regional differences in aerobic glycolysis within the human brain by Tyler Blazey, Abraham Z Snyder, Yi Su, Manu S Goyal, John J Lee, Andrei G Vlassenko, Ana Maria Arbeláez and Marcus E Raichle in Journal of Cerebral Blood Flow & Metabolism